vs
Side-by-side financial comparison of Volato Group, Inc. (SOAR) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $24.9M, roughly 1.9× Volato Group, Inc.). Volato Group, Inc. runs the higher net margin — 14.5% vs -33.9%, a 48.4% gap on every dollar of revenue. On growth, Volato Group, Inc. posted the faster year-over-year revenue change (13632.0% vs -15.6%).
Volato Aeronaves also known as Volato Aeronaves e Compósitos Ltda is a Brazilian aircraft manufacturer.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
SOAR vs STEM — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.9M | $47.1M |
| Net Profit | $3.6M | $-16.0M |
| Gross Margin | 15.2% | 48.9% |
| Operating Margin | 3.5% | -17.7% |
| Net Margin | 14.5% | -33.9% |
| Revenue YoY | 13632.0% | -15.6% |
| Net Profit YoY | 121.3% | 68.8% |
| EPS (diluted) | $0.75 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $47.1M | ||
| Q3 25 | — | $38.2M | ||
| Q2 25 | $24.9M | $38.4M | ||
| Q1 25 | $25.5M | $32.5M | ||
| Q4 24 | — | $55.8M | ||
| Q3 24 | $38.5M | $29.3M | ||
| Q2 24 | — | $34.0M | ||
| Q1 24 | — | $25.5M |
| Q4 25 | — | $-16.0M | ||
| Q3 25 | — | $-23.8M | ||
| Q2 25 | $3.6M | $202.5M | ||
| Q1 25 | $455.0K | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $-4.4M | $-148.3M | ||
| Q2 24 | — | $-582.3M | ||
| Q1 24 | — | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | 15.2% | 33.4% | ||
| Q1 25 | 17.6% | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | 16.6% | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | — | -33.6% | ||
| Q2 25 | 3.5% | -34.8% | ||
| Q1 25 | 9.9% | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | 5.5% | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | — | -33.9% | ||
| Q3 25 | — | -62.2% | ||
| Q2 25 | 14.5% | 527.8% | ||
| Q1 25 | 1.8% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | -11.5% | -506.3% | ||
| Q2 24 | — | -1712.6% | ||
| Q1 24 | — | -283.9% |
| Q4 25 | — | $-4.40 | ||
| Q3 25 | — | $-2.84 | ||
| Q2 25 | $0.75 | $-1.79 | ||
| Q1 25 | $0.03 | $-0.15 | ||
| Q4 24 | — | $-15.29 | ||
| Q3 24 | $-3.76 | $-18.24 | ||
| Q2 24 | — | $-71.81 | ||
| Q1 24 | — | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-7.1M | $-249.4M |
| Total Assets | $13.0M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.9M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | — | $40.8M | ||
| Q1 25 | — | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M | ||
| Q1 24 | — | $112.8M |
| Q4 25 | — | $-249.4M | ||
| Q3 25 | — | $-235.7M | ||
| Q2 25 | $-7.1M | $-214.1M | ||
| Q1 25 | $-15.8M | $-417.5M | ||
| Q4 24 | — | $-398.4M | ||
| Q3 24 | $-19.6M | $-344.1M | ||
| Q2 24 | — | $-203.2M | ||
| Q1 24 | — | $371.6M |
| Q4 25 | — | $308.9M | ||
| Q3 25 | — | $362.6M | ||
| Q2 25 | $13.0M | $379.2M | ||
| Q1 25 | $23.4M | $405.1M | ||
| Q4 24 | — | $437.4M | ||
| Q3 24 | $47.9M | $537.8M | ||
| Q2 24 | — | $691.5M | ||
| Q1 24 | — | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $848.0K | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 0.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.2M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | $848.0K | $-21.3M | ||
| Q1 25 | $-312.0K | $8.5M | ||
| Q4 24 | — | $-14.7M | ||
| Q3 24 | $-3.1M | $-9.4M | ||
| Q2 24 | — | $-11.9M | ||
| Q1 24 | — | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-3.2M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -8.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.24× | -0.11× | ||
| Q1 25 | -0.69× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
